IE
MED icon

Israel Englander’s Medifast MED Stock Holding History

Israel Englander’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-30,000
Closed -$2.02M – 6463
2023
Q4 		$2.02M Buy
30,000
+20,000
+200% +$1.39M ﹤0.01% 3600
2023
Q3 		$749K Buy
+10,000
New +$887K ﹤0.01% 4385

Other funds holding MED

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SCP
Steamboat Capital Partners Rye, New York $468M AUM 80.81% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Israel Englander's MED Position: Q2 2026 in Review

Israel Englander opened a new position in Medifast (MED) in Q2 2026: 47,906 shares worth $508K. The stake represents ﹤0.01% of the portfolio and ranks #4762 among its holdings. This is a return to the name: Israel Englander previously reported a position in MED as recently as Q2 2025.

Israel Englander first reported a position in MED in Q2 2013 and has held it in 48 quarters since. The position peaked at $41.3M in Q1 2023. 112 funds tracked by Wall St. Rank hold MED as of Q2 2026.

  • Israel Englander held 47,906 shares of Medifast worth $508K as of Q2 2026.
  • Medifast was a new Israel Englander position in Q2 2026.
  • Medifast made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #4762 holding.
  • Israel Englander first reported a position in Medifast in Q2 2013 and has held it in 48 quarters since.
  • Israel Englander's Medifast position peaked at $41.3M in Q1 2023.
  • 112 funds tracked by Wall St. Rank held Medifast as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.